Projects funded by the NCN
Thymol-derived 1,3,5-triazines, the non-indole and non-sulfone 5-HT6 receptor ligands, as a starter in search for an innovative treatment of memory- and mood disorders
2018/31/B/NZ7/02160
Keywords:
serotonin 5-HT6 triazine thymol selenium procognitive depression
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_16:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 12
Call: OPUS 16 - announced on 2018-09-14
Amount awarded: 1 997 976 PLN
Project start date (Y-m-d): 2019-07-26
Project end date (Y-m-d): 2023-07-25
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.